Showing results (2391-2400 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|December 13, 2023
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotypeXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.Bone Marrow Transplantation|January 6, 2024
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.Bone Marrow Transplantation|January 3, 2024
Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II TrialMónica Cabrero, Lucia López-Corral, Isidro Jarque, et al.Bone Marrow Transplantation|December 16, 2023
Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantationRyu Yanagisawa, Hiroaki Koyama, Kimikazu Yakushijin, et al.Bone Marrow Transplantation|December 1, 2023
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working PartyJesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.Bone Marrow Transplantation|November 25, 2023
Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP studyA Mussetti, B Rius-Sansalvador, V Moreno, et al.Bone Marrow Transplantation|February 13, 2024
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantationGiovanna Melica, Elaina Preston, Meighan Palazzo, et al.Bone Marrow Transplantation|February 6, 2024
The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemiaMasamitsu Yanada, Shingo Yano, Yachiyo Kuwatsuka, et al.Bone Marrow Transplantation|February 8, 2024
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donorAnnalisa Paviglianiti, Maud Ngoya, Marta Peña, et al.Bone Marrow Transplantation|January 22, 2024
Individualized dose of anti-thymocyte globulin based on weight and pre-transplantation lymphocyte counts in pediatric patients: a single center experienceFrancisco Barriga, Angelica Wietstruck, Clara Schulze-Schiappacasse, et al.Pageof 993